DELIVERING HEALTH INFORMATION
YOU CAN TRUST SINCE 1989
Join the enews community - Terms
MEMBER
MENU
Filter by Categories
Blog
General
Lifestyle

GSK pulls HPV vaccine from US market as take-up rates tumble

Reading time: 1 minute

GSK shipped its final batch of Cervarix at the end of August, and has announced it is pulling the vaccine because of “very low market demand.” The vaccine generated just £3m of revenues in the US for GSK last year.

When the two vaccines were launched, drug industry analysts were forecasting annual sales of up to $10bn, but safety concerns have dampened the take-up among teenage girls, and they have achieved just a 40 per cent coverage of the market.

The CDC is increasing the dosage that must be given from one shot to two, after a committee recommended the new schedule and CDC director Tom Frieden immediately sanctioned the suggestion. The move is being supported by a new advertising campaign that is urging parents to have their teenage daughters vaccinated.

Bryan Hubbard

What do you think? Start a conversation over on the... WDDTY Community

Article Topics: HPV vaccine, vaccine
  • Recent Posts

  • Copyright © 1989 - 2024 WDDTY
    Publishing Registered Office Address: Hill Place House, 55a High Street Wimbledon, London SW19 5BA
    Skip to content